|
Esteve-Pastor MA, Orenes-Piñero E, Roldán V, Lacunza-Ruiz J, Valdés M, Marín F. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality. Cardiol J. 2018;25(1):151-154. doi: 10.5603/CJ.2018.0014. PubMed PMID: 29512103.
AÑO: 2018; IF: 1.743
|
29512103
|
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Orenes-Piñero E, Romiti GF, Romanazzi I, Bai Y, Carmo J, Proietti M, Marín F, Lip GYH. Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation. Am J Cardiol. 2018 Sep 1;122(5):785-792. doi: 10.1016/j.amjcard.2018.05.012. Epub 2018 Jun 2. PubMed PMID: 30049460.
AÑO: 2018; IF: 2.843
|
|
Fernandez-Caballero M, Salmeron D, Dolores Chirlaque M, Chen-Liang TH, Hurtado AM, Garcia Malo MD, Ortuno FJ, Roldan V, Vicente V, Jerez A, De Arriba F. Increasing therapy-related myeloid neoplasms in multiple myeloma. Eur J Clin Invest. 2019 Feb;49(2):e13050. doi: 10.1111/eci.13050. Epub 2018 Dec 7. PubMed PMID: 30422316.
AÑO: 2019; IF: 3.481
|
|
Rios SJ, Rivera-Caravaca JM, Aroca-Valverde C, Reguilon-Gallego L, Castillo-Rodriguez M, Esteve-Pastor MA, Vicente V, Marin F, Roldan V. Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists. QJM. 2019 Mar 1;112(3):183-188. doi: 10.1093/qjmed/hcy250. PubMed PMID: 30380132.
AÑO: 2019; IF: 2.529
|
|
?xml version="1.0" encoding="utf-8"?> <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <pre> 1. Error occurred: cannot get document summary PMID: 30151818
AÑO: 2017; IF: 4.952
|